Why is Trident Texofab falling/rising?

As of 04-September, Trident Texofab Ltd's stock price is currently at Rs 250.20, reflecting an increase of Rs 6.2 or 2.54%. The stock has shown strong performance today, having outperformed its sector by 2.14% and is only 3.52% away from its 52-week high of Rs 259. Notably, the stock has gained after three consecutive days of decline and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past year, Trident Texofab has delivered an impressive return of 466.45%, significantly outperforming the BSE500 index. The company has also reported positive results for the last three consecutive quarters, with net sales growing by 24.20% and operating profit reaching its highest level.
In the broader market context, Trident Texofab's short-term return of 1.40% over the past week exceeds the Sensex's return of 0.80%, indicating a strong relative performance. Despite a recent decline in investor participation, with delivery volume dropping by 46.73% against the 5-day average, the stock remains liquid enough for trading. The majority of shareholders are non-institutional, which may contribute to the stock's volatility. Overall, the combination of strong financial results, positive momentum in stock performance, and favorable comparisons to the benchmark suggests that Trident Texofab is experiencing upward price movement.